
Monopar Therapeutics Inc.
Monopar Therapeutics Inc.(MNPR)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mnpr · 股价预测 · 13 位分析师(近3月)· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$115
Consensus
$110
+81.5% upside
Low
$105
Median: $110 · Last Close: $60.61
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$110.00
81.5% upside
High Target
$115
89.7%
Low Target
$105
73.2%
Current Price
$60.61
as of today
Based on analyst price targets, the MNPR stock price prediction for the next 12 months ranges from $105 to $115. The consensus MNPR price forecast of $110.00 implies 81.5% upside from the current price of $60.61.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $59.60 | ↓ 1.66% |
1-day model range: $59.06–$60.15. Peak: $60.15 (-1.66%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $133 | +120.0% |
| 2028 | $221 | +265.2% |
| 2029 | $302 | +397.8% |
| 2030 | $362 | +497.1% |
| 2031 | — | +562.7% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MNPR · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-30 | Chardan Capital | Maintains | Buy→Buy |
| 2026-02-23 | BTIG | Maintains | Buy→Buy |
| 2026-02-02 | BTIG | Maintains | Buy→Buy |
| 2026-01-29 | Chardan Capital | Maintains | Buy→Buy |
| 2026-01-14 | BTIG | Maintains | Buy→Buy |
| 2025-11-14 | Raymond James | Downgrade ↓ | Strong Buy→Outperform |
| 2025-11-13 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-09 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-06 | Raymond James | Maintains | Strong Buy→Strong Buy |
| 2025-10-02 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Monopar Therapeutics Inc. (MNPR) stock. Of the recent 38 rating actions, 1 were upgrades and 3 were downgrades. 13 analysts currently cover MNPR.
分析师推荐趋势
MNPR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$0M
↓ 99.5% YoY
Revenue Next Year
$15M
↑ 3751.2% YoY
EPS This Year
$-2.66
EPS Next Year
$-3.29
↑ 23.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast MNPR EPS of $-2.66 for the current fiscal year, based on estimates from 9 analysts. The MNPR revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MNPR 股价预测由两类独立数据源支撑:来自 13 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。MNPR 的共识目标价为 $110.00(+81.5% 上行空间),分析师共识为 Buy。
MNPR 的短期预测(明日)为 $59.60(-1.66%)。 MNPR 对 2027 年的股价预测均值为 $133。 MNPR 对 2030 年的预测区间为 $326–$398。
Monopar Therapeutics Inc. 在 NASDAQ 上市,代码 MNPR。MNPR 在 2027 年的整体展望偏积极,在覆盖分析师中约 85% 对应 Buy 共识。
常见问题
MNPR 预测 · 8 个问题根据 13 位华尔街分析师,MNPR 的 12 个月平均目标价为 $110.00,最高 $115.00、最低 $105.00。若有图表,中位目标价可在上方查看。相对当前价 $60.61,隐含约 +81.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.